OrganoClick AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	106.19	127.23	145.87	115.05	110.06
Revenue Growth (YoY)	-16.54%	-12.78%	26.79%	4.53%	14.11%
Cost of Revenue	91.33	95.39	110.48	91.56	91.55
Gross Profit	14.86	31.84	35.39	23.49	18.51
Selling, General & Admin	40.04	36.88	37.23	42.86	39.94
Research & Development	6.33	5.93	6.65	8.13	7.5
Other Operating Expenses	-0.47	-0.43	3.26	-1.18	-1.03
Operating Expenses	45.9	42.38	47.14	49.81	46.41
Operating Income	-31.04	-10.55	-11.75	-26.33	-27.9
Interest Expense	-6.76	-6.17	-4.96	-3.23	-2.65
Interest & Investment Income	0.03	0.04	0.1	0.02	0.07
Currency Exchange Gain (Loss)	-0.41	0.46	-0.2	0.01	-0.22
Other Non Operating Income (Expenses)	0	-0	-0	-	-
EBT Excluding Unusual Items	-38.18	-16.22	-16.81	-29.53	-30.7
Merger & Restructuring Charges	-	-	-	-5.3	-
Gain (Loss) on Sale of Assets	-0.12	0.22	-0.02	2.44	-0.47
Asset Writedown	-	-	-	-9.33	-
Pretax Income	-38.29	-16	-14.09	-41.72	-31.17
Income Tax Expense	-0.29	0.18	0.07	-0.1	-0.14
Earnings From Continuing Operations	-38	-16.18	-14.16	-41.62	-31.03
Minority Interest in Earnings	1.63	-1.79	-1.62	-2.78	-1.65
Net Income	-36.37	-17.97	-15.77	-44.4	-32.69
Net Income to Common	-36.37	-17.97	-15.77	-44.4	-32.69
Shares Outstanding (Basic)	102	98	98	98	96
Shares Outstanding (Diluted)	102	98	98	98	96
Shares Change (YoY)	3.92%	0.10%	-	2.17%	3.66%
EPS (Basic)	-0.36	-0.18	-0.16	-0.45	-0.34
EPS (Diluted)	-0.36	-0.18	-0.16	-0.45	-0.34
Free Cash Flow	-10.51	1.67	-1.23	-29.15	-45.16
Free Cash Flow Per Share	-0.10	0.02	-0.01	-0.30	-0.47
Gross Margin	13.99%	25.02%	24.26%	20.41%	16.82%
Operating Margin	-29.23%	-8.29%	-8.06%	-22.88%	-25.35%
Profit Margin	-34.25%	-14.12%	-10.81%	-38.59%	-29.70%
Free Cash Flow Margin	-9.90%	1.31%	-0.84%	-25.34%	-41.03%
EBITDA	-12.33	-5.18	-6.99	-19.41	-21.68
EBITDA Margin	-11.61%	-4.07%	-4.79%	-16.87%	-19.70%
D&A For EBITDA	18.71	5.37	4.76	6.92	6.22
EBIT	-31.04	-10.55	-11.75	-26.33	-27.9
EBIT Margin	-29.23%	-8.29%	-8.06%	-22.88%	-25.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.